Ensysce Biosciences' Professor Richard Langford Selected to Speak at FDA Public Hearing on the Potential Future Therapeutic Use of Psychedelic Drugs
Go back to Ensysce Biosciences' Professor Richard Langford Selected to Speak at FDA Public Hearing on the Potential Future Therapeutic Use of Psychedelic Drugs| (NASDAQ: ENSC) | Delayed: 0.46 +0.01 (2.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.45 | 52 Week High | $ | |||
| Open | $0.45 | 52 Week Low | $ | |||
| Day High | $0.46 | P/E | N/A | |||
| Day Low | $0.44 | EPS | $ | |||
| Volume | 495,829 | |||||

